Month: January 2026

Chennai, January 27th, 2026: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Methylprednisolone Acetate Injectable Suspension USP, 40mg/mL & 80mg/mL Single Dose vials, a generic…

Read More »

Chennai, January 1st, 2026: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), through its subsidiary companies of Caplin Steriles Limited (CSL) and Caplin One Labs Limited (COL) has acquired 10 approved ANDAs for Injectable and Opthalmic products from a leading Multinational Generic product manufacturing company. These products’ addressable market was $ 473.2 million for…

Read More »